Table 2.
P-values for group comparisons for clinical and hemodynamic variables at baseline vs. following oral benazepril dosing at 0.125, 0.25, or 0.5 mg/kg in 9 healthy beagle dogs.
| Variable | Baseline vs. 0.125 mg/kg | Baseline vs. 0.25 mg/kg | Baseline vs. 0.5 mg/kg | 0.125 vs. 0.25 mg/kg | 0.25 vs. 0.5 mg/kg | 0.125 vs. 0.5 mg/kg |
|---|---|---|---|---|---|---|
| Weight | 0.83 | 0.54 | 0.54 | 0.79 | 0.93 | 0.89 |
| Heart rate | 0.074 | 0.64 | 0.011* | 0.18 | 0.034* | 0.40 |
| BP | 0.010* | 0.044* | 0.14 | 0.54 | 0.57 | 0.24 |
| LVIDd | 0.33 | 0.27 | 1.00 | 0.72 | 0.19 | 0.22 |
| LVIDs | 0.87 | 0.40 | 0.69 | 0.50 | 0.66 | 0.81 |
| LA:Ao | 0.42 | 0.53 | 0.42 | 0.16 | 0.16 | 1.00 |
| FS | 0.57 | 0.033 | 0.88 | 0.11 | 0.046* | 0.68 |
| EDVI | 0.16 | 0.26 | 0.48 | 0.67 | 0.72 | 0.66 |
| ESVI | 0.55 | 0.21 | 0.78 | 0.51 | 0.13 | 0.39 |
| EF | 0.34 | 0.83 | 0.34 | 0.35 | 0.22 | 0.45 |
| E vel | 0.22 | 0.12 | 0.20 | 0.73 | 0.78 | 0.95 |
| A vel | 0.00053* | 0.013* | 0.0018* | 0.23 | 0.43 | 0.66 |
| E:A | 0.015* | 0.10 | 0.0054* | 0.26 | 0.39 | 0.73 |
| IVRT | 0.034* | 0.044* | 0.063 | 0.91 | 0.86 | 0.77 |
| E:IVRT | 0.024* | 0.031* | 0.057 | 0.80 | 0.96 | 0.72 |
Group comparisons were performed using t tests (normally-distributed data) or Wilcoxon rank-sum tests (non-normally distributed data). Significant differences (P-value < 0.05) are designated with bolding and an asterisk (*).
BP blood pressure, LVIDd left ventricular internal diameter in diastole, LVIDs left ventricular internal diameter in systole, LA:Ao a ratio of left atrium to aorta diameter, FS fractional shortening, EDVI end-diastolic volume index, ESVI end-systolic volume index, EF ejection fraction, E vel maximum velocity of early diastolic transmitral inflow, A vel maximum velocity of late diastolic transmitral inflow, E:A ratio of early to late diastolic transmitral inflow, IVRT isovolumic relaxation time, E:IVRT ratio of early diastolic transmitral inflow to IVRT.